Breast Cancer Vaccine to Boost Anti-Tumor Immunity
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington (UW) School of Medicine in Seattle report in a paper published by the journal JAMA Oncology. The findings suggest the vaccine may be able to treat different types of breast cancer.
“Because this was not a randomized clinical trial, the results should be considered preliminary, but the findings are promising enough that the vaccine will now be evaluated in a larger, randomized clinical trial,” said lead author Dr. Mary “Nora” L. Disis, a UW professor of medicine, Division of Medical Oncology, and director of the Cancer Vaccine Institute.
You must be logged in to view this content.
Recent Comments